- Global Pharma News & Resources


London, [19th NOVEMBER 2020] Initiate are delighted to announce the appointment of Andrew Mumford as Managing Director.


Andrew is a pharmaceutical and healthcare global market access expert with a background in both field-based and senior management market access and commercial roles. He moved into consultancy 8 years ago before becoming one of the founding principle consultants at Initiate when it was established as part of the Synaptiq Health group in 2019.


Over the past eighteen months, Initiate has gone from strength to strength with numerous new clients spanning pharmaceutical, biotech and medical devices. The growing team of skilled experts services a wide variety of value-added activities covering market access and HEOR across multiple geographies.


Commenting on the appointment, Chris Edmonds, Chief Executive of the Synaptiq Health group said “Initiate are growing fast, having laid down really strong foundations as global Market Access and HEOR experts. Andrew’s unique experience in developing and implementing access initiatives and the clear leadership skills he has demonstrated means he is the perfect choice to step up and take the reins in our new leadership structure.”


Andrew added “I’m really pleased to be assuming the helm at Initiate. We have been through a period of sustained growth across our core strengths of Market Access and HEOR. We aim to be the trusted, expert access partner to our clients and by really focussing on recruiting the right team with the right skills, we are succeeding in that mission. Ultimately, my goal is to grow further, by continuing to service our clients, complement our expertise and maintain our core values of Collaboration, Empowerment, Integrity and Pragmatism.” 


Andrew’s appointment comes as the team are busy presenting a series of publications at ISPOR Europe. The publications highlight the company’s expertise in the Orphan drugs as well as Cell and Gene Therapy areas. For further information about Initiate and our work please contact Andrew or call +44(0)7932691250


To learn how Synaptiq Health can help you succeed in the pre, peri and post-launch stages of the product lifecycle, contact Chris Edmonds on or call +44 0207 148 0408

Editor Details

  • Company:
    • Initiate Consultancy
  • Name:
    • Initiate Consultancy
Last Updated: 19-Nov-2020